| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/16/2010 | CA2754900A1 Humanized pcrv antibody having anti-pseudomonal activity |
| 09/16/2010 | CA2754862A1 Anti-cd40 antibodies and uses thereof |
| 09/16/2010 | CA2754764A1 Antigen presenting cell targeted cancer vaccines |
| 09/16/2010 | CA2754743A1 Antigen presenting cell targeted anti-viral vaccines |
| 09/16/2010 | CA2754591A1 Generation, expression and characterization of the humanized k33n monoclonal antibody |
| 09/16/2010 | CA2754539A1 Antibody molecules having binding specificity for human il-13 |
| 09/15/2010 | EP2228448A1 MU-1 member of the cytokine receptor family |
| 09/15/2010 | EP2228447A2 Cloning and characterizing of genes associated with long-term memory |
| 09/15/2010 | EP2228446A1 Secreted and transmembrane polypeptieds and nucleic acids encoding the same |
| 09/15/2010 | EP2228392A1 Monoclonal antibody capable of binding to anexelekto, and use thereof |
| 09/15/2010 | EP2228391A2 Immunoglobulins directed against Nogo |
| 09/15/2010 | EP2228390A1 Therapeutic uses of monoclonal antibodies to the angiotensin-II type-1 receptor |
| 09/15/2010 | EP2228389A2 Antibodies against vascular endothelial growth factor 2 |
| 09/15/2010 | EP2228385A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 09/15/2010 | EP2228384A1 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 09/15/2010 | EP2227542A1 Altering high density lipoprotein levels through udp-n-acetyl-alpha-d-galactosamine:polypeptide n-acetlgalactosaminyltransferase (galnt) modulation |
| 09/15/2010 | EP2227490A2 Monoclonal antibodies and binding fragments thereof directed to the melanocortin-4 receptor and their use in the treatment of cachexia and related conditions and diseases |
| 09/15/2010 | EP2227489A2 Method for the detection of dead and dying cells |
| 09/15/2010 | EP2227483A1 Soluble forms of hendra and nipah virus f glycoprotein and uses thereof |
| 09/15/2010 | EP2227256A1 Method for treating bone fracture with anti-sclerostin antibodies |
| 09/15/2010 | EP2227255A1 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods |
| 09/15/2010 | EP2227253A1 Vaccine comprising monocyte or immature myeloid cells(imc) which were loaded with the ligand of natural killer t cell and antigen |
| 09/15/2010 | EP2227249A1 Improved immunizing composition |
| 09/15/2010 | EP1931697B1 Il-17a and il-17f antagonists and methods of using the same |
| 09/15/2010 | EP1576179B1 Methods and compositions for inducing apoptosis in cancer cells |
| 09/15/2010 | EP1572976B1 Modulating immune responses |
| 09/15/2010 | EP1450857B1 Broadly cross-reactive neutralizing antibodies against human immunodeficiency virus selected by env-cd4-co-receptor complexes |
| 09/15/2010 | EP1250055B1 Immune modulation with death receptor-induced apoptosis |
| 09/15/2010 | EP1220944B1 Nuclease inhibitor cocktail |
| 09/15/2010 | CN101836115A Use of tenascin-W as a biomarker for colon cancer |
| 09/15/2010 | CN101835897A Detection of bacterium belonging to genus campylobacter which targets cytolethal distending toxin |
| 09/15/2010 | CN101835896A Production and use of epitope-tagged hepatitis c virus particle |
| 09/15/2010 | CN101835892A CDCA1 peptide and pharmaceutical agent comprising the same |
| 09/15/2010 | CN101835803A Cysteine engineered anti-tenb2 antibodies and antibody drug conjugates |
| 09/15/2010 | CN101835802A Immunoglobulin constant region fc receptor binding agents |
| 09/15/2010 | CN101835792A FOXM1 peptide and medicinal agent comprising the same |
| 09/15/2010 | CN101831434A Anti-human CD45RA rat immune globulin variable region gene and application |
| 09/15/2010 | CN101831407A Hybridoma cell line of monoclonal antibody against African swine fever virus and secreted monoclonal antibody thereof |
| 09/15/2010 | CN101830983A Preparation and application of specific sequence-based aquaporin 4 high titer antibody |
| 09/15/2010 | CN101830982A Preparation method of outer membrane protein monoclonal antibody resisting pseudomonas aeruginosa |
| 09/15/2010 | CN101830980A Chlorothalonil antigen, antibody preparation method and residual chlorothalonil ELISA (Enzyme-Linked Lmmuno Sorbent Assay) detection method |
| 09/15/2010 | CN101830974A Amyloid-beta(1-42) oligomers, derivatives thereof, antibodies for the same, method for production and use therof |
| 09/15/2010 | CN101829325A Pharmaceutical composition for treatment of diseases caused by IL-6 production |
| 09/15/2010 | CN101829324A Treatment of intermediate-and high-grade non-hodgkins lymphoma with anti-CD20 antibody |
| 09/15/2010 | CN101298615B Novel anti-plasmodium falciparum epitope and vaccine containing the same |
| 09/14/2010 | US7795494 Transgenic animals capable of generating antibodies, e.g., human monoclonal antibodies, specific for the product of a gene of interest |
| 09/14/2010 | US7795413 Nucleic acids encoding human anti-NGF neutralizing antibodies as selective NGF pathway inhibitors |
| 09/14/2010 | US7795407 Metastatic breast and colon cancer regulated genes |
| 09/14/2010 | US7795403 Antibodies directed against prothrombin fragment F1+2, the preparation and use thereof |
| 09/14/2010 | US7795402 comprises an antibody is enriched for immunoglobulins having both an antigen-binding portion that binds a Staphylococcus aureus capsular polysaccharide antigen and a constant region that does not bind staphylococcal protein A |
| 09/14/2010 | US7795398 for preventing oomycete infection of potato and/or tomato; disease resistant plants; Phytophthora infestans |
| 09/14/2010 | US7795394 Saitohin gene and uses of same |
| 09/14/2010 | US7795391 Protein showing enhanced expression in cancer cells |
| 09/14/2010 | US7795387 detecting the decreased transcription of messenger RNA transcribed from an RDCVF1 or RDCVF2 polypeptide, in the eye of a human, wherein said decreased transcription is diagnostic of such human's suffering from retinal dystrohy |
| 09/14/2010 | US7795386 selectively inhibit alpha v beta 3 integrin; used in the treatment of diseases associated with angiogenesis and cancer |
| 09/14/2010 | US7795225 inhibitors of chondrosarcoma cell growth that are useful as anti-cancer and anti-tumor agents; inhibitors are peptides having sequences related to cleavage regions of the proenzyme forms of matrix metalloproteinases and that can inhibit the activity of matrix metalloproteinases |
| 09/14/2010 | US7795021 CNS glial restricted precursor cells which generate oligodendrocytes and at least two distinct populations of astrocytes, but not neurons; isolated from a mixture of cells by positive immunoselection with an A2B5 antibody |
| 09/14/2010 | US7795017 plasmid constructs useful for the delivery of DNA vaccines; having a transcription cassette capable of directing the expression of a vaccine nucleic acid insert encoding immunogens derived from any pathogen, including fungi, bacteria and viruses |
| 09/14/2010 | US7795015 Nucleotide squences coding preferential antibody for prevention of and treatment of infections |
| 09/14/2010 | US7794995 use of several sequential steps, including subcellular fractionation to isolate a plasma membrane fraction and the use of gel filtration or chromatography that separates molecules according to their size or affinity; drug screening |
| 09/14/2010 | US7794981 Prosuction of antibodies or (functionalized) fragments thereof derived from heavy chain immunoglobulins of camelidae |
| 09/14/2010 | US7794975 Polypeptide ESDN, polynucleotides encoding the polypeptide, and utility of the polypeptide |
| 09/14/2010 | US7794970 Method for generating F(ab′)2 antibody fragments |
| 09/14/2010 | US7794963 in vivo labeling and identifying recombinantly produced peptides or proteins within an unpermeabilized prokaryotic host cell; comprise at least one tetracysteine tag are labeled in vivo with a biarsenical labeling reagent that binds to the tetracysteine tag and forms a detectable fluorescent complex |
| 09/14/2010 | US7794719 variable regions peptides for immunizing against amyloid plaque formation; biodrug for dementia, Alzheimer's disease, neuropathy, Down's syndrome, Creutzfeld Jacob disease, Parkinson's disease, amyotropic lateral sclerosis; neuroprotectants; hemostatic agent |
| 09/14/2010 | US7794715 T-cell immune response cDNA 7 (TIRC7) antagonist; rheumatoid arthritis; comprising all three complementarity determining regions (CDRs) of the VH and all three complementarity determining regions (CDRs) of the VL variable regions |
| 09/14/2010 | US7794711 Agent for treating chondroma and chondrosarcoma |
| 09/14/2010 | US7794710 Identifying a mammal with, or at risk of developing, cancer; cells of the cancer are identified as expressing B7-H1 molecules on their surfaces, and administering an agent that interferes with interaction between B7-H1 and t-cells |
| 09/14/2010 | CA2478235C Protein purification |
| 09/14/2010 | CA2343569C Mammalian transforming growth factor beta - 9 |
| 09/14/2010 | CA2322792C Polypeptides homologous to vegf and bmp1 |
| 09/14/2010 | CA2146693C Antibodies against epitopes with homology to self antigens, methods of preparation and applications thereof |
| 09/10/2010 | WO2010102244A1 Treatment of leukemias and chronic myeloproliferative diseases with antibodies to epha3 |
| 09/10/2010 | WO2010102241A1 Antibody formulation |
| 09/10/2010 | WO2010102177A1 Glycodelin monoclonal antibodies and methods for their use in the detection of ovarian cancer |
| 09/10/2010 | WO2010102175A1 Fully human antibodies specific to cadm1 |
| 09/10/2010 | WO2010102167A1 Matrix metalloproteinase-7 (mmp-7) monoclonal antibodies and methods for their use in the detection of ovarian cancer |
| 09/10/2010 | WO2010101870A1 Compositions and methods for generating interleukin-35-induced regulatory t cells |
| 09/10/2010 | WO2010101777A1 Detection of melamine |
| 09/10/2010 | WO2010101528A1 A biomarker and treatment for cancer |
| 09/10/2010 | WO2010100878A1 Vangl1 peptides and vaccines including the same |
| 09/10/2010 | WO2010100487A1 An assay for detecting vitamin d and antibodies therefor |
| 09/10/2010 | WO2010100383A1 Anti-rhesus d monoclonal antibody |
| 09/10/2010 | WO2010100135A1 Novel antigen binding dimer-complexes, methods of making/avoiding and uses thereof |
| 09/10/2010 | WO2010099955A1 Protease for wound conditioning and skin care |
| 09/10/2010 | WO2010099918A1 Pharmaceutical composition and method for identifying a cancerous and/or an inflammatory disease in a patient |
| 09/10/2010 | WO2010099612A1 Antibodies and epitopes specific to misfolded prion protein |
| 09/10/2010 | WO2010066868A3 Anti-igf antibodies |
| 09/10/2010 | WO2010054328A3 Compositions and methods for the inhibition of cripto/grp78 complex formation and signaling |
| 09/10/2010 | WO2010053877A3 Mhc ii associated protein and uses thereof |
| 09/10/2010 | WO2010051274A3 Fibronectin type iii domain based scaffold compositions, methods and uses |
| 09/10/2010 | WO2010045345A3 Treatment method |
| 09/10/2010 | WO2010027499A9 Methods, compositions and vaccines relating to neisseria meningitidis antibodies |
| 09/10/2010 | WO2007118986A8 Concentrate of immunoglobulins and f(ab)'2 and/or fab fragments specific of an arbovirus as medicine |
| 09/10/2010 | CA2754528A1 Antibody formulation |
| 09/10/2010 | CA2754044A1 Protease for wound conditioning and skin care |
| 09/10/2010 | CA2753995A1 Treatment of leukemias and chronic myeloproliferative diseases with antibodies to epha3 |
| 09/10/2010 | CA2753756A1 An assay for detecting vitamin d and antibodies therefor |
| 09/10/2010 | CA2753713A1 Glycodelin monoclonal antibodies and methods for their use in the detection of ovarian cancer |
| 09/10/2010 | CA2753702A1 Fully human antibodies specific to cadm1 |